ASX - By Stock
|
IMM |
Re:
Ann: Immutep announces Ph 3 clinical trial collaboration with MSD
|
|
sybasedba
|
11 |
6.8K |
6 |
03/06/24 |
03/06/24 |
ASX - By Stock
|
11
|
6.8K
|
6
|
|
ASX - By Stock
|
IMM |
Re:
EFTI at 90
|
|
sybasedba
|
42 |
18K |
18 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
42
|
18K
|
18
|
|
ASX - By Stock
|
IMM |
Re:
EFTI at 90
|
|
sybasedba
|
42 |
18K |
9 |
07/05/24 |
07/05/24 |
ASX - By Stock
|
42
|
18K
|
9
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
sybasedba
|
2.8K |
1.2M |
15 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
2.8K
|
1.2M
|
15
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Webcast slides for new Efti clinical data in 1st line NSCLC
|
|
sybasedba
|
25 |
11K |
5 |
23/10/23 |
23/10/23 |
ASX - By Stock
|
25
|
11K
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
sybasedba
|
743 |
343K |
18 |
11/07/23 |
11/07/23 |
ASX - By Stock
|
743
|
343K
|
18
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep granted US patent for IMP761 agonist LAG-3 antibody
|
|
sybasedba
|
21 |
9.2K |
9 |
21/06/23 |
21/06/23 |
ASX - By Stock
|
21
|
9.2K
|
9
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
sybasedba
|
2.8K |
1.2M |
4 |
18/05/23 |
18/05/23 |
ASX - By Stock
|
2.8K
|
1.2M
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Excellent initial Overall Survival Benefit in 1st line NSCLC
|
|
sybasedba
|
27 |
15K |
17 |
17/05/23 |
17/05/23 |
ASX - By Stock
|
27
|
15K
|
17
|
|
ASX - By Stock
|
IMM |
Re:
Ann: INSIGHT-003 triple combination data presented at SITC 2022
|
|
sybasedba
|
42 |
21K |
7 |
11/11/22 |
11/11/22 |
ASX - By Stock
|
42
|
21K
|
7
|
|
ASX - By Stock
|
IMM |
Re:
Ann: INSIGHT-003 triple combination data presented at SITC 2022
|
|
sybasedba
|
42 |
21K |
3 |
11/11/22 |
11/11/22 |
ASX - By Stock
|
42
|
21K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Overnight Market report
|
|
sybasedba
|
2.8K |
1.2M |
13 |
08/11/22 |
08/11/22 |
ASX - By Stock
|
2.8K
|
1.2M
|
13
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep to announce new TACTI-002 data at ASCO 2022
|
|
sybasedba
|
47 |
29K |
5 |
17/05/22 |
17/05/22 |
ASX - By Stock
|
47
|
29K
|
5
|
|
ASX - By Stock
|
IMM |
Re:
Relatlimab
|
|
sybasedba
|
33 |
18K |
1 |
21/03/22 |
21/03/22 |
ASX - By Stock
|
33
|
18K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
News: IMM Immutep Reports Phase IIb Final AIPAC Study Results
|
|
sybasedba
|
88 |
35K |
19 |
10/11/21 |
10/11/21 |
ASX - By Stock
|
88
|
35K
|
19
|
|
ASX - By Stock
|
IMM |
Re:
Media
|
|
sybasedba
|
743 |
343K |
1 |
23/09/21 |
23/09/21 |
ASX - By Stock
|
743
|
343K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
News: IMM Immutep Secures Second European Patent For Eftilagimod Alpha, A Soluble Lag-3 Protein, In...
|
|
sybasedba
|
86 |
30K |
16 |
03/06/21 |
03/06/21 |
ASX - By Stock
|
86
|
30K
|
16
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep collaborates with MSD for phase 2b head & neck trial
|
|
sybasedba
|
40 |
23K |
14 |
16/03/21 |
16/03/21 |
ASX - By Stock
|
40
|
23K
|
14
|
|
ASX - By Stock
|
IMM |
Re:
Media Thread
|
|
sybasedba
|
26 |
13K |
13 |
30/12/20 |
30/12/20 |
ASX - By Stock
|
26
|
13K
|
13
|
|
ASX - By Stock
|
IMM |
Re:
Media Thread
|
|
sybasedba
|
26 |
13K |
7 |
30/12/20 |
30/12/20 |
ASX - By Stock
|
26
|
13K
|
7
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Encouraging Phase II TACTI-002 data reported at SITC 2020
|
|
sybasedba
|
51 |
18K |
4 |
10/11/20 |
10/11/20 |
ASX - By Stock
|
51
|
18K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
News: IMM Immutep Signed Agreement With University Hospital Pilsen, Czech Republic
|
|
sybasedba
|
4 |
1.4K |
1 |
23/10/20 |
23/10/20 |
ASX - By Stock
|
4
|
1.4K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep receives A$1,437,826 R&D Tax Incentive
|
|
sybasedba
|
2 |
1.8K |
6 |
22/06/20 |
22/06/20 |
ASX - By Stock
|
2
|
1.8K
|
6
|
|
ASX - By Stock
|
IMM |
Re:
encouraging progress !
|
|
sybasedba
|
58 |
20K |
10 |
01/06/20 |
01/06/20 |
ASX - By Stock
|
58
|
20K
|
10
|
|
ASX - By Stock
|
IMM |
Re:
encouraging progress !
|
|
sybasedba
|
58 |
20K |
0 |
01/06/20 |
01/06/20 |
ASX - By Stock
|
58
|
20K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
encouraging progress !
|
|
sybasedba
|
58 |
20K |
4 |
01/06/20 |
01/06/20 |
ASX - By Stock
|
58
|
20K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep webcast to present new data from 2020 ASCO meeting
|
|
sybasedba
|
8 |
4.6K |
3 |
27/05/20 |
27/05/20 |
ASX - By Stock
|
8
|
4.6K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
A simple view of a simple man...
|
|
sybasedba
|
11 |
9.1K |
2 |
25/05/20 |
25/05/20 |
ASX - By Stock
|
11
|
9.1K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Reports Positive Phase II TACTI-002 Data
|
|
sybasedba
|
28 |
12K |
0 |
28/04/20 |
28/04/20 |
ASX - By Stock
|
28
|
12K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Trading Halt
|
|
sybasedba
|
378 |
132K |
1 |
28/04/20 |
28/04/20 |
ASX - By Stock
|
378
|
132K
|
1
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Reports Positive Phase II TACTI-002 Data
|
|
sybasedba
|
28 |
12K |
6 |
28/04/20 |
28/04/20 |
ASX - By Stock
|
28
|
12K
|
6
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Trading Halt
|
|
sybasedba
|
378 |
132K |
12 |
28/04/20 |
28/04/20 |
ASX - By Stock
|
378
|
132K
|
12
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Enrollment completed for the INSIGHT-004 Study
|
|
sybasedba
|
38 |
17K |
0 |
24/04/20 |
24/04/20 |
ASX - By Stock
|
38
|
17K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Immutep
|
|
sybasedba
|
25 |
13K |
2 |
15/04/20 |
15/04/20 |
ASX - By Stock
|
25
|
13K
|
2
|
|
ASX - By Stock
|
IMM |
Re:
Immutep
|
|
sybasedba
|
25 |
13K |
6 |
15/04/20 |
15/04/20 |
ASX - By Stock
|
25
|
13K
|
6
|
|
ASX - By Stock
|
IMM |
Re:
Ann: EOC Pharma confirms plans to advance Efti in China for MBC
|
|
sybasedba
|
32 |
17K |
7 |
08/04/20 |
08/04/20 |
ASX - By Stock
|
32
|
17K
|
7
|
|
ASX - By Stock
|
IMM |
Re:
CYTLIMIC positive results - YNP01 Phase 1 trial
|
|
sybasedba
|
57 |
23K |
6 |
31/03/20 |
31/03/20 |
ASX - By Stock
|
57
|
23K
|
6
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep Clinical Update & Results Global Webcast Slides
|
|
sybasedba
|
88 |
1.5M |
7 |
28/02/20 |
28/02/20 |
ASX - By Stock
|
88
|
1.5M
|
7
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Change in substantial holding
|
|
sybasedba
|
42 |
40K |
0 |
21/02/20 |
21/02/20 |
ASX - By Stock
|
42
|
40K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
2020.....where the rubber hits the road.
|
|
sybasedba
|
38 |
21K |
4 |
02/01/20 |
02/01/20 |
ASX - By Stock
|
38
|
21K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
share consolidation
|
|
sybasedba
|
6 |
2.6K |
0 |
02/10/19 |
02/10/19 |
ASX - By Stock
|
6
|
2.6K
|
0
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep expands Part A of TACTI-002 due to positive data
|
|
sybasedba
|
66 |
35K |
8 |
28/09/19 |
28/09/19 |
ASX - By Stock
|
66
|
35K
|
8
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Becoming a substantial holder
|
|
sybasedba
|
47 |
18K |
13 |
08/05/19 |
08/05/19 |
ASX - By Stock
|
47
|
18K
|
13
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep enters into collaboration with CYTLIMIC
|
|
sybasedba
|
20 |
11K |
10 |
22/01/19 |
22/01/19 |
ASX - By Stock
|
20
|
11K
|
10
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Positive interim TACTI-mel data presented at SITC
|
|
sybasedba
|
53 |
23K |
7 |
12/11/18 |
12/11/18 |
ASX - By Stock
|
53
|
23K
|
7
|
|
ASX - By Stock
|
IMM |
Re:
The Market...
|
|
sybasedba
|
298 |
146K |
5 |
01/10/18 |
01/10/18 |
ASX - By Stock
|
298
|
146K
|
5
|
|
ASX - By Stock
|
IMM |
Re:
O/N Nasdaq
|
|
sybasedba
|
629 |
256K |
3 |
26/09/18 |
26/09/18 |
ASX - By Stock
|
629
|
256K
|
3
|
|
ASX - By Stock
|
IMM |
Re:
Ann: Immutep to present at Ladenburg Thalmann conference
|
|
sybasedba
|
9 |
5.7K |
10 |
26/09/18 |
26/09/18 |
ASX - By Stock
|
9
|
5.7K
|
10
|
|
ASX - By Stock
|
IMM |
Re:
News: IMM Immutep Says Co Entered Into Clinical Trial Collaboration And Supply Agreement
|
|
sybasedba
|
21 |
10K |
4 |
24/09/18 |
24/09/18 |
ASX - By Stock
|
21
|
10K
|
4
|
|
ASX - By Stock
|
IMM |
Re:
News: IMM Immutep Says Co Entered Into Clinical Trial Collaboration And Supply Agreement
|
|
sybasedba
|
21 |
10K |
4 |
24/09/18 |
24/09/18 |
ASX - By Stock
|
21
|
10K
|
4
|
|